Low concentrations (1-3 µg/ml) of 5-bromodeoxyuridine (BrdU) reversibly suppress pigmentation in a highly pigmented clone (B 5 59) of cultured B16 mouse melanoma cells . We have found that unpigmented cells (clone C 3 471), derived by long-term culture of B 5 59 cells in 1 ug of BrdU/ml, were completely amelanotic with no biochemically or cytochemically detectable tyrosinase activity or ultrastructural evidence of premelanosomes . The process by which pigmentation is suppressed was studied in B 559 cells during a 7-day period of growth with BrdU (3 µg/ml) . Assays of tyrosinase activity showed that activity was reduced after 1 day and decreased progressively, approaching zero by 7 days . A quantitatively minor part of this reduction was directly attributable to the appearance of a dialyzable inhibitor of tyrosinase activity. Acrylamide gel electrophoresis revealed two bands of activity corresponding in Rx values to the T, and T2 forms of soluble tyrosinase . Both were progressively reduced during growth with BrdU but one form (T 1 ) was consistently affected earlier than the other (T2 ) . Ultrastructural-cytochemical studies also showed an early effect on the localization of tyrosinase reaction product . At day 3, reaction product was no longer present in Golgi saccules and Golgi-associated smooth surfaced tubules, but was still seen within premelanosomes, compound melanosomes, and occasional Golgi-associated vesicles . By 7 days tyrosinase reaction product was usually not demonstrable . The number of premelanosomes was progressively decreased during growth with BrdU . Premelanosomes became concentrated in the juxtanuclear region and at day 3 many were contained within abnormally large and numerous compound melanosomes . Premelanosomes and compound melanosomes were rarely seen at 7 days, by which time the cultures were nearly amelanotic . The coordinated suppression of melanogenesis by BrdU may provide a useful model in which to study the normal regulation of this process .
0 6Low concentrations of 5-bromodeoxyuridine (BrdU) have been shown to suppress differentiated functions preferentially in a variety of cell types (1-9) . Silagi and Bruce (5) reported that treatment of melanotic melanoma cells (clone B559) with BrdU altered cellular morphology and suppressed both pigmentation and tumorigenicity while cell proliferation continued at a near normal level . These effects appeared dependent upon incorporation of the BrdU into cellular DNA as an analogue of thymidine . The effects upon morphology, pigmentation, and tumorigenicity were reversible upon growth of the cells in normal medium (5, 10) . The molecular basis of this reversible effect is